Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2008, for Innovative Acquisitions Corp. (Note: The input metadata references "PUMA BIOTECHNOLOGY, INC.", but the filing text explicitly identifies the registrant as Innovative Acquisitions Corp.). The company is a Delaware corporation organized on April 27, 2007, classified as a "shell company" and a "blank check" company. It has no active business operations and was formed solely to seek a merger or acquisition with an operating business.
Key Financial Metrics
| Metric | Value (Sep 30, 2008) | Value (Dec 31, 2007) |
|---|---|---|
| Cash and Cash Equivalents | $72 | $1,407 |
| Total Assets | $72 | $1,407 |
| Total Liabilities | $2,249 | $0 |
| Stockholders' Equity (Deficit) | ($2,177) | $1,407 |
| Revenue | $0 | $0 |
| Net Loss (9 months ended Sep 30, 2008) | ($11,834) | N/A |
| Net Loss (Cumulative from Inception) | ($26,927) | N/A |
| Net Cash Used in Operating Activities (9 months) | ($9,585) | N/A |
| Net Cash Provided by Financing (9 months) | $8,250 | N/A |
Capital Structure: 3,000,000 shares of common stock outstanding as of November 12, 2008. No preferred stock issued.
Material Changes vs. Prior Period
- Liquidity Decline: Cash reserves decreased by approximately 95% from $1,407 at year-end 2007 to $72 at September 30, 2008.
- Liability Increase: The company moved from zero liabilities to $2,249 in accounts payable, primarily due to accrued professional fees.
- Equity Deficit: Stockholders' equity turned negative, resulting in a deficit of $2,177, driven by cumulative net losses exceeding total capital contributions.
- Capital Contributions: During the nine months ended September 30, 2008, directors contributed $8,250 in cash to fund operations, though no new shares were issued for these specific contributions.
Outlook, Risks, and Management Commentary
Going Concern: Management explicitly states that the financial statements are prepared on a going concern basis, which raises substantial doubt about the company's ability to continue. The company has generated no revenue since inception and is dependent on shareholder financial support and equity financing to survive.
Business Plan: The company intends to identify and acquire a target business. It anticipates incurring costs for SEC filings and acquisition investigations over the next 12 months. There is no assurance that a business combination will be achieved.
Risks:
- Financial Instability: Potential targets may be financially unstable or early-stage companies.
- Funding Dependency: Operations rely entirely on capital contributions from related parties or new investors.
- Blank Check Status: As a shell company with no specific business plan, the company faces regulatory scrutiny and market limitations.
Unusual Items: The net loss for the period consists entirely of legal, accounting, and audit fees required for regulatory compliance (Form 10-Q and 10-KSB filings).
Investor Verification Checklist
- Cash Runway: Verify if the remaining $72 in cash is sufficient to meet immediate filing obligations or if additional capital is required immediately.
- Related Party Support: Confirm the willingness and ability of directors to continue providing capital contributions to cover the $2,249 in accounts payable and future operating costs.
- Acquisition Progress: Assess if any specific target companies have been identified or if the company remains in the initial search phase.
- Shareholder Dilution: Review the terms of future financing, as the company may need to issue new shares to raise capital, potentially diluting existing holders.